{"issuance_frequency":"","notes_translated":{"fr":"Les examinateurs scientifiques de Santé Canada évaluent les données pour évaluer les avantages et les risques potentiels d'un médicament ou d'un vaccin. Ils examinent également les renseignements qui seront fournis aux professionnels de la santé et aux consommateurs au sujet du produit. Après l'examen, nous pouvons autoriser la vente du médicament ou du vaccin au Canada seulement si les avantages du produit l'emportent sur les risques potentiels.","en":"Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"f8200e19-de85-440f-8214-fa54b64ea2f5","metadata_created":"2020-11-04T15:10:26.970538","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-11-04T15:10:26.970544","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-11-04","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["COVID-19","pandémie","autorisation de médicament et de vaccin","autoriser la vente du médicaments ou du vaccin","avantages et risques potentiels d'un médicament ou d'un vaccin","professionnels de la santé et consommateurs","avantages","risques potentiels"],"en":["COVID-19","pandemic","drug and vaccine authorizations","authorize the drug or vaccine for sale","potential benefits and risks of a drug or vaccine","health care practitioners and consumers","benefits of the product","potential risks"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Autorisation de médicament et de vaccin contre la COVID-19 : Aperçu","en":"Drug and vaccine authorizations for COVID-19: Overview"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"f8200e19-de85-440f-8214-fa54b64ea2f5","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"44a4b4aa-e00d-4a9a-97a9-de383cdcc274","related_relationship":"","name_translated":{"fr":"Autorisation de médicament et de vaccin contre la COVID-19 : Aperçu","en":"Drug and vaccine authorizations for COVID-19: Overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Drug and vaccine authorizations for COVID-19: Overview","language":["en"],"created":"2020-11-04T15:10:27.112769","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization.html","last_modified":null,"position":0,"revision_id":"db313e75-8ad3-401b-b1e0-675885ca7ca5","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"f8200e19-de85-440f-8214-fa54b64ea2f5","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"675db23c-c360-4c6b-ac12-23cdd9add2fd","related_relationship":"","name_translated":{"fr":"Autorisation de médicament et de vaccin contre la COVID-19 : Aperçu","en":"Drug and vaccine authorizations for COVID-19: Overview"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Drug and vaccine authorizations for COVID-19: Overview","language":["fr"],"created":"2020-11-04T15:10:27.112775","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/autorisations.html","last_modified":null,"position":1,"revision_id":"db313e75-8ad3-401b-b1e0-675885ca7ca5","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-09-13 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"f8200e19-de85-440f-8214-fa54b64ea2f5","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Drug and vaccine authorizations for COVID-19: Overview","revision_id":"db313e75-8ad3-401b-b1e0-675885ca7ca5"}